nodes	percent_of_prediction	percent_of_DWPC	metapath
Omeprazole—Cytochrome P450 2C19 Inhibitors—Efavirenz—acquired immunodeficiency syndrome	0.562	1	CiPCiCtD
Omeprazole—CYP11A1—Saquinavir—acquired immunodeficiency syndrome	0.0332	0.103	CbGbCtD
Omeprazole—ABCC3—Lamivudine—acquired immunodeficiency syndrome	0.0164	0.0507	CbGbCtD
Omeprazole—ABCG2—Nelfinavir—acquired immunodeficiency syndrome	0.01	0.0311	CbGbCtD
Omeprazole—ABCG2—Saquinavir—acquired immunodeficiency syndrome	0.00907	0.0281	CbGbCtD
Omeprazole—ABCG2—Ritonavir—acquired immunodeficiency syndrome	0.00907	0.0281	CbGbCtD
Omeprazole—ABCG2—Zidovudine—acquired immunodeficiency syndrome	0.0087	0.0269	CbGbCtD
Omeprazole—ABCG2—Lamivudine—acquired immunodeficiency syndrome	0.00673	0.0208	CbGbCtD
Omeprazole—CYP2C8—Delavirdine—acquired immunodeficiency syndrome	0.00638	0.0197	CbGbCtD
Omeprazole—CYP2C8—Amprenavir—acquired immunodeficiency syndrome	0.00638	0.0197	CbGbCtD
Omeprazole—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.00629	0.0195	CbGbCtD
Omeprazole—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.00592	0.0183	CbGbCtD
Omeprazole—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.00581	0.018	CbGbCtD
Omeprazole—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.00546	0.0169	CbGbCtD
Omeprazole—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.00546	0.0169	CbGbCtD
Omeprazole—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.00535	0.0166	CbGbCtD
Omeprazole—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.00535	0.0166	CbGbCtD
Omeprazole—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.00523	0.0162	CbGbCtD
Omeprazole—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.00494	0.0153	CbGbCtD
Omeprazole—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.00492	0.0152	CbGbCtD
Omeprazole—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.00492	0.0152	CbGbCtD
Omeprazole—CYP2C8—Ritonavir—acquired immunodeficiency syndrome	0.00483	0.015	CbGbCtD
Omeprazole—CYP2C8—Saquinavir—acquired immunodeficiency syndrome	0.00483	0.015	CbGbCtD
Omeprazole—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.00478	0.0148	CbGbCtD
Omeprazole—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.00477	0.0148	CbGbCtD
Omeprazole—CYP2C8—Zidovudine—acquired immunodeficiency syndrome	0.00463	0.0143	CbGbCtD
Omeprazole—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.00462	0.0143	CbGbCtD
Omeprazole—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0045	0.0139	CbGbCtD
Omeprazole—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0045	0.0139	CbGbCtD
Omeprazole—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.00448	0.0139	CbGbCtD
Omeprazole—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.00445	0.0138	CbGbCtD
Omeprazole—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.00445	0.0138	CbGbCtD
Omeprazole—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.00432	0.0134	CbGbCtD
Omeprazole—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.00414	0.0128	CbGbCtD
Omeprazole—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.00407	0.0126	CbGbCtD
Omeprazole—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.00407	0.0126	CbGbCtD
Omeprazole—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.00406	0.0126	CbGbCtD
Omeprazole—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.00406	0.0126	CbGbCtD
Omeprazole—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.00389	0.012	CbGbCtD
Omeprazole—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.00384	0.0119	CbGbCtD
Omeprazole—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.00374	0.0116	CbGbCtD
Omeprazole—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.00373	0.0115	CbGbCtD
Omeprazole—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.00373	0.0115	CbGbCtD
Omeprazole—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.00362	0.0112	CbGbCtD
Omeprazole—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.00351	0.0109	CbGbCtD
Omeprazole—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.00341	0.0106	CbGbCtD
Omeprazole—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.00337	0.0104	CbGbCtD
Omeprazole—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.00337	0.0104	CbGbCtD
Omeprazole—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.00327	0.0101	CbGbCtD
Omeprazole—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.00327	0.0101	CbGbCtD
Omeprazole—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.00323	0.01	CbGbCtD
Omeprazole—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.00314	0.00971	CbGbCtD
Omeprazole—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.00308	0.00954	CbGbCtD
Omeprazole—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.00308	0.00954	CbGbCtD
Omeprazole—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.00304	0.00942	CbGbCtD
Omeprazole—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.00286	0.00886	CbGbCtD
Omeprazole—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.00286	0.00886	CbGbCtD
Omeprazole—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.00259	0.00801	CbGbCtD
Omeprazole—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.00259	0.00801	CbGbCtD
Omeprazole—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.00243	0.00751	CbGbCtD
Omeprazole—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00223	0.00691	CbGbCtD
Omeprazole—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00217	0.00671	CbGbCtD
Omeprazole—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00196	0.00607	CbGbCtD
Omeprazole—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00196	0.00607	CbGbCtD
Omeprazole—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00188	0.00582	CbGbCtD
Omeprazole—ATP4A—blood plasma—acquired immunodeficiency syndrome	0.00141	0.0751	CbGeAlD
Omeprazole—ATP4B—digestive system—acquired immunodeficiency syndrome	0.00125	0.0663	CbGeAlD
Omeprazole—ABCC3—blood plasma—acquired immunodeficiency syndrome	0.00072	0.0382	CbGeAlD
Omeprazole—ATP4A—digestive system—acquired immunodeficiency syndrome	0.000544	0.0289	CbGeAlD
Omeprazole—ATP4A—blood—acquired immunodeficiency syndrome	0.000518	0.0275	CbGeAlD
Omeprazole—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.000494	0.0262	CbGeAlD
Omeprazole—CYP2C18—digestive system—acquired immunodeficiency syndrome	0.000447	0.0237	CbGeAlD
Omeprazole—CYP2C8—blood plasma—acquired immunodeficiency syndrome	0.000431	0.0229	CbGeAlD
Omeprazole—ATP4A—nervous system—acquired immunodeficiency syndrome	0.000421	0.0223	CbGeAlD
Omeprazole—ATP4A—central nervous system—acquired immunodeficiency syndrome	0.000405	0.0215	CbGeAlD
Omeprazole—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.000404	0.0214	CbGeAlD
Omeprazole—CYP2C18—vagina—acquired immunodeficiency syndrome	0.000395	0.021	CbGeAlD
Omeprazole—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.000383	0.0203	CbGeAlD
Omeprazole—CYP11A1—blood—acquired immunodeficiency syndrome	0.00034	0.018	CbGeAlD
Omeprazole—ATP4A—brain—acquired immunodeficiency syndrome	0.000322	0.0171	CbGeAlD
Omeprazole—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000292	0.0155	CbGeAlD
Omeprazole—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000288	0.0153	CbGeAlD
Omeprazole—ABCC3—digestive system—acquired immunodeficiency syndrome	0.000277	0.0147	CbGeAlD
Omeprazole—CYP11A1—nervous system—acquired immunodeficiency syndrome	0.000276	0.0146	CbGeAlD
Omeprazole—CYP1B1—skin of body—acquired immunodeficiency syndrome	0.000271	0.0144	CbGeAlD
Omeprazole—CYP11A1—central nervous system—acquired immunodeficiency syndrome	0.000266	0.0141	CbGeAlD
Omeprazole—ABCC3—blood—acquired immunodeficiency syndrome	0.000264	0.014	CbGeAlD
Omeprazole—ABCC3—lung—acquired immunodeficiency syndrome	0.000231	0.0123	CbGeAlD
Omeprazole—CYP1B1—lymphoid tissue—acquired immunodeficiency syndrome	0.000219	0.0116	CbGeAlD
Omeprazole—CYP1B1—digestive system—acquired immunodeficiency syndrome	0.000217	0.0115	CbGeAlD
Omeprazole—ABCC3—nervous system—acquired immunodeficiency syndrome	0.000214	0.0114	CbGeAlD
Omeprazole—CYP11A1—brain—acquired immunodeficiency syndrome	0.000211	0.0112	CbGeAlD
Omeprazole—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.000207	0.011	CbGeAlD
Omeprazole—CYP1B1—blood—acquired immunodeficiency syndrome	0.000206	0.0109	CbGeAlD
Omeprazole—ABCC3—central nervous system—acquired immunodeficiency syndrome	0.000206	0.0109	CbGeAlD
Omeprazole—CYP11A1—lymph node—acquired immunodeficiency syndrome	0.000204	0.0108	CbGeAlD
Omeprazole—CYP1A1—skin of body—acquired immunodeficiency syndrome	0.000191	0.0102	CbGeAlD
Omeprazole—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.00019	0.0101	CbGeAlD
Omeprazole—CYP2C19—blood—acquired immunodeficiency syndrome	0.000181	0.00961	CbGeAlD
Omeprazole—CYP1B1—lung—acquired immunodeficiency syndrome	0.000181	0.0096	CbGeAlD
Omeprazole—CYP2C19—vagina—acquired immunodeficiency syndrome	0.000168	0.00891	CbGeAlD
Omeprazole—CYP1B1—nervous system—acquired immunodeficiency syndrome	0.000168	0.00889	CbGeAlD
Omeprazole—ABCC3—brain—acquired immunodeficiency syndrome	0.000164	0.00868	CbGeAlD
Omeprazole—CYP1B1—central nervous system—acquired immunodeficiency syndrome	0.000161	0.00856	CbGeAlD
Omeprazole—ABCC3—lymph node—acquired immunodeficiency syndrome	0.000158	0.00839	CbGeAlD
Omeprazole—CYP2C8—blood—acquired immunodeficiency syndrome	0.000158	0.00839	CbGeAlD
Omeprazole—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.000155	0.00824	CbGeAlD
Omeprazole—ABCG2—blood—acquired immunodeficiency syndrome	0.000154	0.00815	CbGeAlD
Omeprazole—CYP1A1—digestive system—acquired immunodeficiency syndrome	0.000153	0.00812	CbGeAlD
Omeprazole—ABCG2—bone marrow—acquired immunodeficiency syndrome	0.000149	0.00789	CbGeAlD
Omeprazole—ABCG2—spinal cord—acquired immunodeficiency syndrome	0.000148	0.00786	CbGeAlD
Omeprazole—CYP1A2—blood—acquired immunodeficiency syndrome	0.000148	0.00785	CbGeAlD
Omeprazole—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000147	0.00782	CbGeAlD
Omeprazole—CYP2C8—vagina—acquired immunodeficiency syndrome	0.000146	0.00777	CbGeAlD
Omeprazole—CYP1A1—blood—acquired immunodeficiency syndrome	0.000146	0.00774	CbGeAlD
Omeprazole—ABCG2—vagina—acquired immunodeficiency syndrome	0.000142	0.00756	CbGeAlD
Omeprazole—CYP2C9—blood—acquired immunodeficiency syndrome	0.00014	0.00745	CbGeAlD
Omeprazole—CYP1A1—vagina—acquired immunodeficiency syndrome	0.000135	0.00718	CbGeAlD
Omeprazole—ABCG2—lung—acquired immunodeficiency syndrome	0.000135	0.00715	CbGeAlD
Omeprazole—CYP1A2—lung—acquired immunodeficiency syndrome	0.00013	0.00688	CbGeAlD
Omeprazole—CYP1B1—brain—acquired immunodeficiency syndrome	0.000128	0.00679	CbGeAlD
Omeprazole—CYP1A1—lung—acquired immunodeficiency syndrome	0.000128	0.00679	CbGeAlD
Omeprazole—CYP1B1—lymph node—acquired immunodeficiency syndrome	0.000124	0.00657	CbGeAlD
Omeprazole—CYP1A1—nervous system—acquired immunodeficiency syndrome	0.000118	0.00628	CbGeAlD
Omeprazole—CYP1A1—central nervous system—acquired immunodeficiency syndrome	0.000114	0.00605	CbGeAlD
Omeprazole—ABCB1—retina—acquired immunodeficiency syndrome	0.000113	0.00601	CbGeAlD
Omeprazole—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000112	0.00596	CbGeAlD
Omeprazole—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000111	0.00587	CbGeAlD
Omeprazole—CYP3A4—blood—acquired immunodeficiency syndrome	0.000107	0.00568	CbGeAlD
Omeprazole—CYP2D6—blood—acquired immunodeficiency syndrome	0.000105	0.00559	CbGeAlD
Omeprazole—CYP2C8—brain—acquired immunodeficiency syndrome	9.81e-05	0.0052	CbGeAlD
Omeprazole—ABCG2—brain—acquired immunodeficiency syndrome	9.53e-05	0.00506	CbGeAlD
Omeprazole—ABCG2—lymph node—acquired immunodeficiency syndrome	9.21e-05	0.00489	CbGeAlD
Omeprazole—CYP1A1—brain—acquired immunodeficiency syndrome	9.05e-05	0.0048	CbGeAlD
Omeprazole—CYP1A1—lymph node—acquired immunodeficiency syndrome	8.75e-05	0.00464	CbGeAlD
Omeprazole—CYP3A4—nervous system—acquired immunodeficiency syndrome	8.69e-05	0.00461	CbGeAlD
Omeprazole—CYP2D6—nervous system—acquired immunodeficiency syndrome	8.55e-05	0.00454	CbGeAlD
Omeprazole—CYP3A4—central nervous system—acquired immunodeficiency syndrome	8.37e-05	0.00444	CbGeAlD
Omeprazole—CYP2D6—central nervous system—acquired immunodeficiency syndrome	8.23e-05	0.00437	CbGeAlD
Omeprazole—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	8.05e-05	0.00427	CbGeAlD
Omeprazole—ABCB1—digestive system—acquired immunodeficiency syndrome	7.95e-05	0.00422	CbGeAlD
Omeprazole—ABCB1—blood—acquired immunodeficiency syndrome	7.58e-05	0.00402	CbGeAlD
Omeprazole—ABCB1—bone marrow—acquired immunodeficiency syndrome	7.33e-05	0.00389	CbGeAlD
Omeprazole—ABCB1—spinal cord—acquired immunodeficiency syndrome	7.3e-05	0.00387	CbGeAlD
Omeprazole—ABCB1—vagina—acquired immunodeficiency syndrome	7.02e-05	0.00373	CbGeAlD
Omeprazole—ABCB1—lung—acquired immunodeficiency syndrome	6.64e-05	0.00352	CbGeAlD
Omeprazole—CYP2D6—brain—acquired immunodeficiency syndrome	6.54e-05	0.00347	CbGeAlD
Omeprazole—ABCB1—nervous system—acquired immunodeficiency syndrome	6.15e-05	0.00326	CbGeAlD
Omeprazole—ABCB1—central nervous system—acquired immunodeficiency syndrome	5.92e-05	0.00314	CbGeAlD
Omeprazole—ABCB1—brain—acquired immunodeficiency syndrome	4.7e-05	0.00249	CbGeAlD
Omeprazole—ABCB1—lymph node—acquired immunodeficiency syndrome	4.54e-05	0.00241	CbGeAlD
Omeprazole—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	3.97e-05	0.000412	CcSEcCtD
Omeprazole—Pruritus—Stavudine—acquired immunodeficiency syndrome	3.96e-05	0.000411	CcSEcCtD
Omeprazole—Asthenia—Abacavir—acquired immunodeficiency syndrome	3.96e-05	0.000411	CcSEcCtD
Omeprazole—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	3.96e-05	0.00041	CcSEcCtD
Omeprazole—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	3.95e-05	0.00041	CcSEcCtD
Omeprazole—Chest pain—Ritonavir—acquired immunodeficiency syndrome	3.95e-05	0.00041	CcSEcCtD
Omeprazole—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	3.95e-05	0.00041	CcSEcCtD
Omeprazole—Myalgia—Ritonavir—acquired immunodeficiency syndrome	3.95e-05	0.00041	CcSEcCtD
Omeprazole—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	3.93e-05	0.000408	CcSEcCtD
Omeprazole—Anaemia—Lamivudine—acquired immunodeficiency syndrome	3.93e-05	0.000408	CcSEcCtD
Omeprazole—Anxiety—Ritonavir—acquired immunodeficiency syndrome	3.93e-05	0.000408	CcSEcCtD
Omeprazole—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	3.92e-05	0.000407	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	3.91e-05	0.000406	CcSEcCtD
Omeprazole—Pruritus—Abacavir—acquired immunodeficiency syndrome	3.9e-05	0.000405	CcSEcCtD
Omeprazole—Fatigue—Indinavir—acquired immunodeficiency syndrome	3.9e-05	0.000405	CcSEcCtD
Omeprazole—Anorexia—Delavirdine—acquired immunodeficiency syndrome	3.9e-05	0.000405	CcSEcCtD
Omeprazole—Discomfort—Ritonavir—acquired immunodeficiency syndrome	3.9e-05	0.000405	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	3.9e-05	0.000404	CcSEcCtD
Omeprazole—Cough—Saquinavir—acquired immunodeficiency syndrome	3.89e-05	0.000404	CcSEcCtD
Omeprazole—Angioedema—Lamivudine—acquired immunodeficiency syndrome	3.89e-05	0.000404	CcSEcCtD
Omeprazole—Pain—Indinavir—acquired immunodeficiency syndrome	3.87e-05	0.000402	CcSEcCtD
Omeprazole—Constipation—Indinavir—acquired immunodeficiency syndrome	3.87e-05	0.000402	CcSEcCtD
Omeprazole—Insomnia—Efavirenz—acquired immunodeficiency syndrome	3.87e-05	0.000401	CcSEcCtD
Omeprazole—Urticaria—Zidovudine—acquired immunodeficiency syndrome	3.87e-05	0.000401	CcSEcCtD
Omeprazole—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	3.86e-05	0.000401	CcSEcCtD
Omeprazole—Hypertension—Saquinavir—acquired immunodeficiency syndrome	3.85e-05	0.0004	CcSEcCtD
Omeprazole—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	3.85e-05	0.000399	CcSEcCtD
Omeprazole—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	3.85e-05	0.000399	CcSEcCtD
Omeprazole—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	3.84e-05	0.000399	CcSEcCtD
Omeprazole—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	3.84e-05	0.000398	CcSEcCtD
Omeprazole—Malaise—Lamivudine—acquired immunodeficiency syndrome	3.84e-05	0.000398	CcSEcCtD
Omeprazole—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	3.83e-05	0.000398	CcSEcCtD
Omeprazole—Nausea—Didanosine—acquired immunodeficiency syndrome	3.83e-05	0.000398	CcSEcCtD
Omeprazole—Vertigo—Lamivudine—acquired immunodeficiency syndrome	3.82e-05	0.000397	CcSEcCtD
Omeprazole—Confusional state—Ritonavir—acquired immunodeficiency syndrome	3.81e-05	0.000396	CcSEcCtD
Omeprazole—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	3.81e-05	0.000396	CcSEcCtD
Omeprazole—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	3.81e-05	0.000395	CcSEcCtD
Omeprazole—Somnolence—Efavirenz—acquired immunodeficiency syndrome	3.8e-05	0.000395	CcSEcCtD
Omeprazole—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	3.8e-05	0.000394	CcSEcCtD
Omeprazole—Chest pain—Saquinavir—acquired immunodeficiency syndrome	3.8e-05	0.000394	CcSEcCtD
Omeprazole—Myalgia—Saquinavir—acquired immunodeficiency syndrome	3.8e-05	0.000394	CcSEcCtD
Omeprazole—Anxiety—Saquinavir—acquired immunodeficiency syndrome	3.79e-05	0.000393	CcSEcCtD
Omeprazole—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	3.77e-05	0.000392	CcSEcCtD
Omeprazole—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	3.77e-05	0.000392	CcSEcCtD
Omeprazole—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	3.76e-05	0.000391	CcSEcCtD
Omeprazole—Discomfort—Saquinavir—acquired immunodeficiency syndrome	3.75e-05	0.00039	CcSEcCtD
Omeprazole—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	3.73e-05	0.000387	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	3.73e-05	0.000387	CcSEcCtD
Omeprazole—Shock—Ritonavir—acquired immunodeficiency syndrome	3.72e-05	0.000386	CcSEcCtD
Omeprazole—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	3.72e-05	0.000386	CcSEcCtD
Omeprazole—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	3.72e-05	0.000386	CcSEcCtD
Omeprazole—Cough—Lamivudine—acquired immunodeficiency syndrome	3.71e-05	0.000385	CcSEcCtD
Omeprazole—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	3.71e-05	0.000385	CcSEcCtD
Omeprazole—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	3.71e-05	0.000385	CcSEcCtD
Omeprazole—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	3.7e-05	0.000384	CcSEcCtD
Omeprazole—Dizziness—Stavudine—acquired immunodeficiency syndrome	3.7e-05	0.000384	CcSEcCtD
Omeprazole—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	3.7e-05	0.000384	CcSEcCtD
Omeprazole—Insomnia—Delavirdine—acquired immunodeficiency syndrome	3.7e-05	0.000384	CcSEcCtD
Omeprazole—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	3.69e-05	0.000383	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	3.69e-05	0.000383	CcSEcCtD
Omeprazole—Vomiting—Nevirapine—acquired immunodeficiency syndrome	3.69e-05	0.000383	CcSEcCtD
Omeprazole—Fatigue—Efavirenz—acquired immunodeficiency syndrome	3.69e-05	0.000383	CcSEcCtD
Omeprazole—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	3.67e-05	0.000381	CcSEcCtD
Omeprazole—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	3.67e-05	0.000381	CcSEcCtD
Omeprazole—Confusional state—Saquinavir—acquired immunodeficiency syndrome	3.67e-05	0.000381	CcSEcCtD
Omeprazole—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	3.66e-05	0.00038	CcSEcCtD
Omeprazole—Constipation—Efavirenz—acquired immunodeficiency syndrome	3.66e-05	0.00038	CcSEcCtD
Omeprazole—Pain—Efavirenz—acquired immunodeficiency syndrome	3.66e-05	0.00038	CcSEcCtD
Omeprazole—Rash—Nevirapine—acquired immunodeficiency syndrome	3.66e-05	0.000379	CcSEcCtD
Omeprazole—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	3.65e-05	0.000379	CcSEcCtD
Omeprazole—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	3.65e-05	0.000379	CcSEcCtD
Omeprazole—Dizziness—Abacavir—acquired immunodeficiency syndrome	3.65e-05	0.000379	CcSEcCtD
Omeprazole—Somnolence—Delavirdine—acquired immunodeficiency syndrome	3.64e-05	0.000377	CcSEcCtD
Omeprazole—Headache—Nevirapine—acquired immunodeficiency syndrome	3.63e-05	0.000377	CcSEcCtD
Omeprazole—Myalgia—Lamivudine—acquired immunodeficiency syndrome	3.62e-05	0.000376	CcSEcCtD
Omeprazole—Chest pain—Lamivudine—acquired immunodeficiency syndrome	3.62e-05	0.000376	CcSEcCtD
Omeprazole—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	3.62e-05	0.000376	CcSEcCtD
Omeprazole—Infection—Saquinavir—acquired immunodeficiency syndrome	3.62e-05	0.000375	CcSEcCtD
Omeprazole—Anxiety—Lamivudine—acquired immunodeficiency syndrome	3.61e-05	0.000375	CcSEcCtD
Omeprazole—Anorexia—Ritonavir—acquired immunodeficiency syndrome	3.61e-05	0.000374	CcSEcCtD
Omeprazole—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	3.6e-05	0.000374	CcSEcCtD
Omeprazole—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	3.6e-05	0.000374	CcSEcCtD
Omeprazole—Urticaria—Indinavir—acquired immunodeficiency syndrome	3.6e-05	0.000373	CcSEcCtD
Omeprazole—Shock—Saquinavir—acquired immunodeficiency syndrome	3.58e-05	0.000372	CcSEcCtD
Omeprazole—Discomfort—Lamivudine—acquired immunodeficiency syndrome	3.58e-05	0.000372	CcSEcCtD
Omeprazole—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	3.58e-05	0.000371	CcSEcCtD
Omeprazole—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	3.58e-05	0.000371	CcSEcCtD
Omeprazole—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	3.57e-05	0.000371	CcSEcCtD
Omeprazole—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	3.57e-05	0.000371	CcSEcCtD
Omeprazole—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	3.57e-05	0.00037	CcSEcCtD
Omeprazole—Vomiting—Stavudine—acquired immunodeficiency syndrome	3.56e-05	0.000369	CcSEcCtD
Omeprazole—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	3.56e-05	0.000369	CcSEcCtD
Omeprazole—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	3.54e-05	0.000368	CcSEcCtD
Omeprazole—Rash—Nelfinavir—acquired immunodeficiency syndrome	3.54e-05	0.000368	CcSEcCtD
Omeprazole—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	3.54e-05	0.000367	CcSEcCtD
Omeprazole—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	3.54e-05	0.000367	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	3.53e-05	0.000367	CcSEcCtD
Omeprazole—Rash—Stavudine—acquired immunodeficiency syndrome	3.53e-05	0.000366	CcSEcCtD
Omeprazole—Fatigue—Delavirdine—acquired immunodeficiency syndrome	3.53e-05	0.000366	CcSEcCtD
Omeprazole—Dermatitis—Stavudine—acquired immunodeficiency syndrome	3.53e-05	0.000366	CcSEcCtD
Omeprazole—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	3.52e-05	0.000366	CcSEcCtD
Omeprazole—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	3.52e-05	0.000365	CcSEcCtD
Omeprazole—Headache—Nelfinavir—acquired immunodeficiency syndrome	3.52e-05	0.000365	CcSEcCtD
Omeprazole—Headache—Stavudine—acquired immunodeficiency syndrome	3.51e-05	0.000364	CcSEcCtD
Omeprazole—Vomiting—Abacavir—acquired immunodeficiency syndrome	3.51e-05	0.000364	CcSEcCtD
Omeprazole—Confusional state—Lamivudine—acquired immunodeficiency syndrome	3.5e-05	0.000364	CcSEcCtD
Omeprazole—Pain—Delavirdine—acquired immunodeficiency syndrome	3.5e-05	0.000363	CcSEcCtD
Omeprazole—Constipation—Delavirdine—acquired immunodeficiency syndrome	3.5e-05	0.000363	CcSEcCtD
Omeprazole—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	3.5e-05	0.000363	CcSEcCtD
Omeprazole—Asthenia—Zidovudine—acquired immunodeficiency syndrome	3.49e-05	0.000362	CcSEcCtD
Omeprazole—Rash—Abacavir—acquired immunodeficiency syndrome	3.48e-05	0.000361	CcSEcCtD
Omeprazole—Dermatitis—Abacavir—acquired immunodeficiency syndrome	3.47e-05	0.000361	CcSEcCtD
Omeprazole—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	3.47e-05	0.000361	CcSEcCtD
Omeprazole—Anorexia—Saquinavir—acquired immunodeficiency syndrome	3.47e-05	0.00036	CcSEcCtD
Omeprazole—Headache—Abacavir—acquired immunodeficiency syndrome	3.46e-05	0.000359	CcSEcCtD
Omeprazole—Infection—Lamivudine—acquired immunodeficiency syndrome	3.45e-05	0.000358	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	3.45e-05	0.000358	CcSEcCtD
Omeprazole—Nausea—Nevirapine—acquired immunodeficiency syndrome	3.44e-05	0.000357	CcSEcCtD
Omeprazole—Pruritus—Zidovudine—acquired immunodeficiency syndrome	3.44e-05	0.000357	CcSEcCtD
Omeprazole—Insomnia—Ritonavir—acquired immunodeficiency syndrome	3.42e-05	0.000355	CcSEcCtD
Omeprazole—Shock—Lamivudine—acquired immunodeficiency syndrome	3.42e-05	0.000355	CcSEcCtD
Omeprazole—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	3.41e-05	0.000354	CcSEcCtD
Omeprazole—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	3.4e-05	0.000353	CcSEcCtD
Omeprazole—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	3.4e-05	0.000353	CcSEcCtD
Omeprazole—Urticaria—Efavirenz—acquired immunodeficiency syndrome	3.4e-05	0.000353	CcSEcCtD
Omeprazole—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	3.38e-05	0.000351	CcSEcCtD
Omeprazole—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	3.38e-05	0.000351	CcSEcCtD
Omeprazole—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	3.37e-05	0.00035	CcSEcCtD
Omeprazole—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	3.37e-05	0.00035	CcSEcCtD
Omeprazole—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	3.37e-05	0.00035	CcSEcCtD
Omeprazole—Somnolence—Ritonavir—acquired immunodeficiency syndrome	3.36e-05	0.000349	CcSEcCtD
Omeprazole—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	3.36e-05	0.000349	CcSEcCtD
Omeprazole—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	3.35e-05	0.000347	CcSEcCtD
Omeprazole—Nausea—Nelfinavir—acquired immunodeficiency syndrome	3.34e-05	0.000346	CcSEcCtD
Omeprazole—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	3.33e-05	0.000346	CcSEcCtD
Omeprazole—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	3.33e-05	0.000346	CcSEcCtD
Omeprazole—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	3.33e-05	0.000346	CcSEcCtD
Omeprazole—Nausea—Stavudine—acquired immunodeficiency syndrome	3.33e-05	0.000345	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	3.32e-05	0.000344	CcSEcCtD
Omeprazole—Anorexia—Lamivudine—acquired immunodeficiency syndrome	3.31e-05	0.000344	CcSEcCtD
Omeprazole—Insomnia—Saquinavir—acquired immunodeficiency syndrome	3.29e-05	0.000342	CcSEcCtD
Omeprazole—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	3.29e-05	0.000341	CcSEcCtD
Omeprazole—Nausea—Abacavir—acquired immunodeficiency syndrome	3.28e-05	0.00034	CcSEcCtD
Omeprazole—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	3.27e-05	0.000339	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	3.27e-05	0.000339	CcSEcCtD
Omeprazole—Fatigue—Ritonavir—acquired immunodeficiency syndrome	3.26e-05	0.000339	CcSEcCtD
Omeprazole—Urticaria—Delavirdine—acquired immunodeficiency syndrome	3.25e-05	0.000337	CcSEcCtD
Omeprazole—Asthenia—Indinavir—acquired immunodeficiency syndrome	3.25e-05	0.000337	CcSEcCtD
Omeprazole—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	3.25e-05	0.000337	CcSEcCtD
Omeprazole—Somnolence—Saquinavir—acquired immunodeficiency syndrome	3.24e-05	0.000336	CcSEcCtD
Omeprazole—Pain—Ritonavir—acquired immunodeficiency syndrome	3.24e-05	0.000336	CcSEcCtD
Omeprazole—Constipation—Ritonavir—acquired immunodeficiency syndrome	3.24e-05	0.000336	CcSEcCtD
Omeprazole—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	3.23e-05	0.000336	CcSEcCtD
Omeprazole—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	3.23e-05	0.000336	CcSEcCtD
Omeprazole—Dizziness—Zidovudine—acquired immunodeficiency syndrome	3.22e-05	0.000334	CcSEcCtD
Omeprazole—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	3.21e-05	0.000333	CcSEcCtD
Omeprazole—Pruritus—Indinavir—acquired immunodeficiency syndrome	3.2e-05	0.000332	CcSEcCtD
Omeprazole—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	3.17e-05	0.000329	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	3.17e-05	0.000328	CcSEcCtD
Omeprazole—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	3.15e-05	0.000327	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	3.14e-05	0.000326	CcSEcCtD
Omeprazole—Insomnia—Lamivudine—acquired immunodeficiency syndrome	3.14e-05	0.000326	CcSEcCtD
Omeprazole—Fatigue—Saquinavir—acquired immunodeficiency syndrome	3.14e-05	0.000326	CcSEcCtD
Omeprazole—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	3.12e-05	0.000324	CcSEcCtD
Omeprazole—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	3.12e-05	0.000324	CcSEcCtD
Omeprazole—Pain—Saquinavir—acquired immunodeficiency syndrome	3.11e-05	0.000323	CcSEcCtD
Omeprazole—Constipation—Saquinavir—acquired immunodeficiency syndrome	3.11e-05	0.000323	CcSEcCtD
Omeprazole—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	3.1e-05	0.000321	CcSEcCtD
Omeprazole—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	3.1e-05	0.000321	CcSEcCtD
Omeprazole—Vomiting—Zidovudine—acquired immunodeficiency syndrome	3.09e-05	0.000321	CcSEcCtD
Omeprazole—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	3.09e-05	0.000321	CcSEcCtD
Omeprazole—Somnolence—Lamivudine—acquired immunodeficiency syndrome	3.09e-05	0.000321	CcSEcCtD
Omeprazole—Rash—Zidovudine—acquired immunodeficiency syndrome	3.07e-05	0.000318	CcSEcCtD
Omeprazole—Asthenia—Efavirenz—acquired immunodeficiency syndrome	3.07e-05	0.000318	CcSEcCtD
Omeprazole—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	3.07e-05	0.000318	CcSEcCtD
Omeprazole—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	3.06e-05	0.000317	CcSEcCtD
Omeprazole—Headache—Zidovudine—acquired immunodeficiency syndrome	3.05e-05	0.000316	CcSEcCtD
Omeprazole—Pruritus—Efavirenz—acquired immunodeficiency syndrome	3.03e-05	0.000314	CcSEcCtD
Omeprazole—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	3.02e-05	0.000313	CcSEcCtD
Omeprazole—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	3.01e-05	0.000313	CcSEcCtD
Omeprazole—Urticaria—Ritonavir—acquired immunodeficiency syndrome	3.01e-05	0.000312	CcSEcCtD
Omeprazole—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	3e-05	0.000311	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	3e-05	0.000311	CcSEcCtD
Omeprazole—Fatigue—Lamivudine—acquired immunodeficiency syndrome	3e-05	0.000311	CcSEcCtD
Omeprazole—Dizziness—Indinavir—acquired immunodeficiency syndrome	2.99e-05	0.000311	CcSEcCtD
Omeprazole—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	2.99e-05	0.00031	CcSEcCtD
Omeprazole—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	2.99e-05	0.00031	CcSEcCtD
Omeprazole—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	2.98e-05	0.000309	CcSEcCtD
Omeprazole—Constipation—Lamivudine—acquired immunodeficiency syndrome	2.97e-05	0.000308	CcSEcCtD
Omeprazole—Pain—Lamivudine—acquired immunodeficiency syndrome	2.97e-05	0.000308	CcSEcCtD
Omeprazole—Asthenia—Delavirdine—acquired immunodeficiency syndrome	2.94e-05	0.000305	CcSEcCtD
Omeprazole—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	2.93e-05	0.000304	CcSEcCtD
Omeprazole—Pruritus—Delavirdine—acquired immunodeficiency syndrome	2.89e-05	0.0003	CcSEcCtD
Omeprazole—Urticaria—Saquinavir—acquired immunodeficiency syndrome	2.89e-05	0.0003	CcSEcCtD
Omeprazole—Nausea—Zidovudine—acquired immunodeficiency syndrome	2.89e-05	0.0003	CcSEcCtD
Omeprazole—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	2.88e-05	0.000299	CcSEcCtD
Omeprazole—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	2.88e-05	0.000299	CcSEcCtD
Omeprazole—Vomiting—Indinavir—acquired immunodeficiency syndrome	2.88e-05	0.000299	CcSEcCtD
Omeprazole—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	2.86e-05	0.000297	CcSEcCtD
Omeprazole—Rash—Indinavir—acquired immunodeficiency syndrome	2.85e-05	0.000296	CcSEcCtD
Omeprazole—Dermatitis—Indinavir—acquired immunodeficiency syndrome	2.85e-05	0.000296	CcSEcCtD
Omeprazole—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	2.84e-05	0.000295	CcSEcCtD
Omeprazole—Headache—Indinavir—acquired immunodeficiency syndrome	2.84e-05	0.000294	CcSEcCtD
Omeprazole—Dizziness—Efavirenz—acquired immunodeficiency syndrome	2.83e-05	0.000293	CcSEcCtD
Omeprazole—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	2.8e-05	0.000291	CcSEcCtD
Omeprazole—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	2.79e-05	0.000289	CcSEcCtD
Omeprazole—Urticaria—Lamivudine—acquired immunodeficiency syndrome	2.76e-05	0.000286	CcSEcCtD
Omeprazole—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	2.75e-05	0.000285	CcSEcCtD
Omeprazole—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	2.75e-05	0.000285	CcSEcCtD
Omeprazole—Vomiting—Efavirenz—acquired immunodeficiency syndrome	2.72e-05	0.000282	CcSEcCtD
Omeprazole—Asthenia—Ritonavir—acquired immunodeficiency syndrome	2.71e-05	0.000282	CcSEcCtD
Omeprazole—Dizziness—Delavirdine—acquired immunodeficiency syndrome	2.71e-05	0.000281	CcSEcCtD
Omeprazole—Rash—Efavirenz—acquired immunodeficiency syndrome	2.7e-05	0.00028	CcSEcCtD
Omeprazole—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	2.69e-05	0.00028	CcSEcCtD
Omeprazole—Nausea—Indinavir—acquired immunodeficiency syndrome	2.69e-05	0.000279	CcSEcCtD
Omeprazole—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	2.68e-05	0.000278	CcSEcCtD
Omeprazole—Headache—Efavirenz—acquired immunodeficiency syndrome	2.68e-05	0.000278	CcSEcCtD
Omeprazole—Pruritus—Ritonavir—acquired immunodeficiency syndrome	2.68e-05	0.000278	CcSEcCtD
Omeprazole—Asthenia—Saquinavir—acquired immunodeficiency syndrome	2.61e-05	0.000271	CcSEcCtD
Omeprazole—Vomiting—Delavirdine—acquired immunodeficiency syndrome	2.6e-05	0.00027	CcSEcCtD
Omeprazole—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	2.59e-05	0.000269	CcSEcCtD
Omeprazole—Rash—Delavirdine—acquired immunodeficiency syndrome	2.58e-05	0.000268	CcSEcCtD
Omeprazole—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	2.58e-05	0.000267	CcSEcCtD
Omeprazole—Pruritus—Saquinavir—acquired immunodeficiency syndrome	2.58e-05	0.000267	CcSEcCtD
Omeprazole—Headache—Delavirdine—acquired immunodeficiency syndrome	2.56e-05	0.000266	CcSEcCtD
Omeprazole—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	2.56e-05	0.000266	CcSEcCtD
Omeprazole—Nausea—Efavirenz—acquired immunodeficiency syndrome	2.54e-05	0.000264	CcSEcCtD
Omeprazole—Dizziness—Ritonavir—acquired immunodeficiency syndrome	2.5e-05	0.00026	CcSEcCtD
Omeprazole—Asthenia—Lamivudine—acquired immunodeficiency syndrome	2.49e-05	0.000259	CcSEcCtD
Omeprazole—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	2.49e-05	0.000259	CcSEcCtD
Omeprazole—Pruritus—Lamivudine—acquired immunodeficiency syndrome	2.46e-05	0.000255	CcSEcCtD
Omeprazole—Nausea—Delavirdine—acquired immunodeficiency syndrome	2.43e-05	0.000252	CcSEcCtD
Omeprazole—Dizziness—Saquinavir—acquired immunodeficiency syndrome	2.41e-05	0.00025	CcSEcCtD
Omeprazole—Vomiting—Ritonavir—acquired immunodeficiency syndrome	2.41e-05	0.00025	CcSEcCtD
Omeprazole—Rash—Ritonavir—acquired immunodeficiency syndrome	2.39e-05	0.000248	CcSEcCtD
Omeprazole—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	2.38e-05	0.000247	CcSEcCtD
Omeprazole—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	2.38e-05	0.000247	CcSEcCtD
Omeprazole—Headache—Ritonavir—acquired immunodeficiency syndrome	2.37e-05	0.000246	CcSEcCtD
Omeprazole—Vomiting—Saquinavir—acquired immunodeficiency syndrome	2.32e-05	0.00024	CcSEcCtD
Omeprazole—Dizziness—Lamivudine—acquired immunodeficiency syndrome	2.3e-05	0.000238	CcSEcCtD
Omeprazole—Rash—Saquinavir—acquired immunodeficiency syndrome	2.3e-05	0.000238	CcSEcCtD
Omeprazole—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	2.29e-05	0.000238	CcSEcCtD
Omeprazole—Headache—Saquinavir—acquired immunodeficiency syndrome	2.28e-05	0.000237	CcSEcCtD
Omeprazole—Nausea—Ritonavir—acquired immunodeficiency syndrome	2.25e-05	0.000233	CcSEcCtD
Omeprazole—Vomiting—Lamivudine—acquired immunodeficiency syndrome	2.21e-05	0.000229	CcSEcCtD
Omeprazole—Rash—Lamivudine—acquired immunodeficiency syndrome	2.19e-05	0.000227	CcSEcCtD
Omeprazole—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	2.19e-05	0.000227	CcSEcCtD
Omeprazole—Headache—Lamivudine—acquired immunodeficiency syndrome	2.18e-05	0.000226	CcSEcCtD
Omeprazole—Nausea—Saquinavir—acquired immunodeficiency syndrome	2.16e-05	0.000224	CcSEcCtD
Omeprazole—Nausea—Lamivudine—acquired immunodeficiency syndrome	2.06e-05	0.000214	CcSEcCtD
